Co-Pay Relief Program Unveils New Financial Assistance for Cancer Genetic & Genomic Testing

Patient Advocate Foundation’s Co-Pay Relief program eases cost burden through launch of cancer genetic & genomic testing silo.

PAF’s Co-Pay Relief (CPR) program is offering a first of its kind fund – providing $250 per year to insured patients undergoing cancer genetic and/or genomic testing – regardless of whether their insurer covers the testing for which they’re seeking assistance. This new silo expands the program’s existing service which can provide direct financial assistance to qualified patients with co-payments, co-insurance or cost-sharing associated with pharmaceutical treatments and/or prescription medications through funds dedicated to specific disease states.We are pleased to announce that the cancer genetic and genomic testing fund is now accepting applications for new patients – fund details are provided below:

                  CANCER GENETIC AND GENOMIC TESTING: Maximum Annual Award Amount: $250

Eligibility Criteria:

  • Patient must be insured – however insurance does not have to cover testing for which patient seeks assistance
  • Patient must have a confirmed treatment plan that includes undergoing cancer genetic and/or genomic testing
  • Patient must reside and receive treatment in the United States.
  • Patient’s income must fall below 400% of the Federal Poverty Guideline(FPG) with consideration of the Cost of Living Index(COLI) and the number in the household

The CPR Program offers four points of entry:


To learn more about cancer genetic and genomic testing please visit